// App-Quantinova.ai

358 : Development of an allogenic FAP CAR iNKT product to target tumor stroma and modulate the tumor microenvironment

Researchers

Presenter

  • Xavier Michelet

Principal Investigators

  • Martyna Popis

  • Shannon Boi

  • Magda Niedzielska

  • Reed Masakayan

  • Efrat Altman Sharoni

  • Paul Ibbett

  • Deborah Wright

  • Barbara Barbara Kalinowska

  • Justin Keith

  • Bishnu Joshi

  • Moira Pinzan Rossi

  • Rachel Smith

  • Burcu Yigit

  • Olivier Le Tonqueze

  • Eleni Chantzoura

  • Marc van Dijk

Medical Centers

  • MiNK Therapeutics, Lexington, MA, USA

  • MiNK Therapeutics, Cambridge, UK

  • Agenus, Lexington, MA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • IL-15

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved